Kura Oncology (KURA) Interest Coverage Ratio (2010 - 2026)
Kura Oncology (KURA) posted quarterly Interest Coverage Ratio of 9.98 for Q1 2026, up 93.83% year-over-year from 5.15 in Q1 2025, and up 95.72% quarter-over-quarter from 232.9 in Q4 2025.
Kura Oncology (KURA) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Kura Oncology (KURA) has reported Interest Coverage Ratio for 8 consecutive years, with 9.98 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 93.83% year-over-year to 9.98; the TTM figure through Mar 2026 stood at 34.69 (down 165.7% YoY), while the FY2025 annual figure was 0.83, down 20.44% from the prior year.
- Interest Coverage Ratio advanced to 9.98 in Q1 2026 per KURA's latest filing, from 232.9 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 1.64 in Q2 2025 and bottomed at 757.66 in Q4 2024.
- Historically, Interest Coverage Ratio has averaged 182.32 across 3 years, with a median of 131.05 in 2024.
- On a YoY basis, Interest Coverage Ratio climbed as much as 98.37% in 2025 and fell as far as 64.97% in 2025.
- Kura Oncology's Interest Coverage Ratio stood at 757.66 in 2024, then surged by 69.26% to 232.9 in 2025, then surged by 95.72% to 9.98 in 2026.
- Business Quant data shows KURA's Interest Coverage Ratio at 9.98 in Q1 2026, 232.9 in Q4 2025, and 147.23 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Kura Oncology | 966.11 Mn | 966.11 Mn | 20.63 Mn | -3.13 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.13 |
| Mar 31, 2026 | -9.98 |
| Dec 31, 2025 | -232.90 |
| Sep 30, 2025 | -147.23 |
| Jun 30, 2025 | -1.64 |
| Mar 31, 2025 | -161.75 |
| Dec 31, 2024 | -757.66 |
| Sep 30, 2024 | -131.05 |
| Jun 30, 2024 | -100.67 |
| Mar 31, 2024 | -98.05 |
| Dec 31, 2014 | -0.26 |
| Sep 30, 2014 | -2.86 |
| Jun 30, 2014 | -3.19 |
| Mar 31, 2014 | -2.54 |
| Dec 31, 2013 | -4.86 |
| Sep 30, 2013 | -2.69 |
| Jun 30, 2013 | -4.22 |
| Mar 31, 2013 | -3.75 |
| Dec 31, 2012 | -6.51 |
| Sep 30, 2012 | -3.68 |